1[1]Sakakara Y. Cilia injury during virus infection in chickens. Rhinolo gy, 1985,23(4) :283
2[2]Felix K, Pairet M, Zimmermann R. The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cys- teine. A pulse radiolysis study, Life Sci, 1996,59(14): 1141
3[3]Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airway diease. Eur RespirJ, 1997,10(2) :482
4[4]Wauer RR, Schmalisch G. Randomized double blind trial of Ambroxol for the treatment of respiratory distress svndrome. Eur J Pediatr, 1992,151 (5) :357
5[5]Paganin F. Evaluation of the effects of arnbroxol on the ofloxacinconcentrations in bronchial tissues in COPD patients with infectious exacerbation. Biopharm Drug Dispos, 1995,16 (5): 393
6[4]Jackson RT. Mechanism of action of some commonly used drugs. Otolaryngol Head Neck Surg. 1991 ; 104: 433- 440.
7[7]Black MJ Remsen KA. Rhinitis medicamentosa. Can Med Assoc J. 1980;122:881-884.
8[8]Ohashi Y,Nakai Y,Ikeoka H,et al. Regeneration of nasal mucosa following mechanical injury. Acta Otolaryngol.1991; (Suppl 486): 193- 201.
9[9]Graf PM. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nsaal spray. ORL. 1998 ; 60: 334- 338.
10[11]Graf PM. Overruse of oxy-and xylometazoline nasal sprays. Changes in nasal mucosal swelling and histamine sensitivity in healthy subjects and patients with rhinitsis medicamentosa. Thesis paper. Karolinska Institute, Sweden, 1994 ;ISBN 91-628-1395-1
